Consensus on medical treatment of metastatic breast cancer1,2
Which treatment when?
Efficacy of combination therapy versus monotherapy
Role of taxanes
The role of anthracyclines/anthraquinones in metastatic breast cancer
Treatment choices for second-line chemotherapy of metastatic breast cancer
Chemotherapy of metastatic breast cancer: is more better?
Definition of an optimal first-line chemotherapy in metastatic breast cancer
Chemotherapy for advanced breast cancer - how long should it continue?
Chemotherapy or endocrine therapy for metastatic breast cancer?
Aromatase inhibitors as first line treatment: treatment cascade after failure of aromatase inhibitors
Testing to define the target Her-2/neu
Trastuzumab monotherapy
Trastuzumab in combination with chemotherapy
Her-2/neu as predictive marker for endocrine therapy and chemotherapy in patients with metastatic breast cancer
Trastuzumab: how long? Treatment strategies after failure
Bisphosphonates in metastatic breast cancer
The role of erythropoietin in the supportive care of breast cancer
Hormone replacement therapy after breast cancer?
Psychosocial support for women with advanced breast cancer
High dose chemotherapy and autologous stem cell transplantation for metastatic breast cancer: is there a place?
Future directions in the treatment of metastatic breast cancer
Future directions in the treatment of breast cancer - cellular interventions using dendritic cells